# Effect of Treatment With Insulin Sensitizer on Arterial Properties, Metabolic Parameters and Liver Function in Patients With Nonalcoholic Fatty Liver Disease

> **NCT01084486** · PHASE1,PHASE2 · COMPLETED · sponsor: **Wolfson Medical Center**

## Conditions studied

- Nonalcoholic Fatty Liver Disease

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT01084486
- **Lead sponsor:** Wolfson Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2010-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01084486

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01084486, "Effect of Treatment With Insulin Sensitizer on Arterial Properties, Metabolic Parameters and Liver Function in Patients With Nonalcoholic Fatty Liver Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01084486. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*